BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8501913)

  • 1. Modeling T cell-antigen presenting cell interactions.
    Fishman MA; Perelson AS
    J Theor Biol; 1993 Feb; 160(3):311-42. PubMed ID: 8501913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral IL-10 gene transfer inhibits DTH responses to soluble antigens: evidence for involvement of genetically modified dendritic cells and macrophages.
    Whalen JD; Thomson AW; Lu L; Robbins PD; Evans CH
    Mol Ther; 2001 Dec; 4(6):543-50. PubMed ID: 11735338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing role of dendritic cells and macrophages in the induction of delayed-type hypersensitivity responses to PPD.
    Mukherjee S; Katz DR; Rook GA
    Immunology; 1986 Oct; 59(2):229-34. PubMed ID: 3490434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
    Cua DJ; Coffman RL; Stohlman SA
    J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams.
    Rodriguez-Pena R; Lopez S; Mayorga C; Antunez C; Fernandez TD; Torres MJ; Blanca M
    J Allergy Clin Immunol; 2006 Oct; 118(4):949-56. PubMed ID: 17030251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feedback activation of T-cell antigen-presenting cells during interactions with T-cell responders.
    Mannie MD; Walker MR
    J Leukoc Biol; 2001 Aug; 70(2):252-60. PubMed ID: 11493617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins.
    Lopez S; Torres MJ; Rodríguez-Pena R; Blanca-Lopez N; Fernandez TD; Antunez C; Canto G; de Luque V; Mayorga C
    Br J Dermatol; 2009 Feb; 160(2):259-65. PubMed ID: 18945304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol consumption modifies dendritic cell antigen presentation in mice.
    Heinz R; Waltenbaugh C
    Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between heterochronic cells in the formation of delayed-type hypersensitivity.
    Adambekov DA; Morozov VL
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(2):217-22. PubMed ID: 1512458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated CD8+ T lymphocytes induce differentiation of monocytes to dendritic cells and restore the stimulatory capacity of interleukin 10-treated antigen-presenting cells.
    Wirths S; Reichert J; Grünebach F; Brossart P
    Cancer Res; 2002 Sep; 62(17):5065-8. PubMed ID: 12208762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
    Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
    Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-presenting cells for unprimed T cells.
    Sprent J; Schaefer M
    Immunol Today; 1989 Jan; 10(1):17-23. PubMed ID: 2526637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease and immunosenescence.
    Kim HJ; Barajas B; Chan RC; Nel AE
    J Allergy Clin Immunol; 2007 May; 119(5):1225-33. PubMed ID: 17335885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular requirements for cutaneous sensitivity elicitation.
    Aoki I
    Exp Clin Immunogenet; 1985; 2(3):164-73. PubMed ID: 2856185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
    Chaux P; Moutet M; Faivre J; Martin F; Martin M
    Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resident tissue macrophages within the normal rat iris lack immunosuppressive activity and are effective antigen-presenting cells.
    Steptoe RJ; McMenamin PG; Holt PG
    Ocul Immunol Inflamm; 2000 Sep; 8(3):177-87. PubMed ID: 11120579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.